Adipose-derived stem cells exhibit antioxidative and antiapoptotic properties to rescue ischemic acute kidney injury in rats

Plastic and Reconstructive Surgery

Volumn 132, Issue 6, 2013, Pages

  Shih, Yu Chung ^a   Lee, Pei Ying ^a   Cheng, Henrich ^a   Tsai, Chi Han ^a   Ma, Hsu ^b   Tarng, Der Cherng ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE KIDNEY INJURY; ADIPOSE TISSUE; ANIMAL; APOPTOSIS; CYTOLOGY; KIDNEY TUBULE; MALE; METABOLISM; OXIDATIVE STRESS; PATHOLOGY; PHYSIOLOGY; RAT; REPERFUSION INJURY; SPRAGUE DAWLEY RAT; STEM CELL; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME; ACUTE KIDNEY FAILURE; ARTICLE;

ACUTE KIDNEY INJURY; ADIPOSE TISSUE; ANIMALS; APOPTOSIS; KIDNEY TUBULES; MALE; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; STEM CELL TRANSPLANTATION; STEM CELLS; TREATMENT OUTCOME;

EID: 84889038975     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e3182a806ce     Document Type: Article

References (32)

1. Thadhani R, Pascual M, Bonventre JV. Acute renal failure. N Engl J Med. 1996;334:1448-1460.
2. Schrier RW, Wang W, Poole B, Mitra A. Acute renal failure: Defnitions, diagnosis, pathogenesis, and therapy. J Clin Invest. 2004;114:5-14.
3. Ratcliffe PJ, Moonen CT, Holloway PA, Ledingham JG, Radda GK. Acute renal failure in hemorrhagic hypotension: Cellular energetics and renal function. Kidney Int. 1986;30:355-360.
4. Morigi M, Imberti B, Zoja C, et al. Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. J Am Soc Nephrol. 2004;15:1794-1804.
5. Morigi M, Introna M, Imberti B, et al. Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice. Stem Cells 2008;26:2075-2082.
6. Bi B, Schmitt R, Israilova M, Nishio H, Cantley LG. Stromal cells protect against acute tubular injury via an endocrine effect. J Am Soc Nephrol. 2007;18:2486-2496.
7. Herrera MB, Bussolati B, Bruno S, Fonsato V, Romanazzi GM, Camussi G. Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury. Int J Mol Med. 2004;14:1035-1041.
8. Tögel F, Hu Z, Weiss K, Isaac J, Lange C, Westenfelder C. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol. 2005;289:F31-F42.
9. Lange C, Tögel F, Ittrich H, et al. Administered mes-enchymal stem cells enhance recovery from ischemia/reperfusion-induced acute renal failure in rats. Kidney Int. 2005;68:1613-1617.
10. Zuk PA, Zhu M, Mizuno H, et al. Multilineage cells from human adipose tissue: Implications for cell-based therapies. Tissue Eng. 2001;7:211-228.
11. Feng Z, Ting J, Alfonso Z, et al. Fresh and cryopreserved, uncultured adipose tissue-derived stem and regenerative cells ameliorate ischemia-reperfusion-induced acute kidney injury. Nephrol Dial Transplant. 2010;25:3874-3884.
12. Chen YT, Sun CK, Lin YC, et al. Adipose-derived mesenchy-mal stem cell protects kidneys against ischemia-reperfusion injury through suppressing oxidative stress and infamma-tory reaction. J Transl Med. 2011;9:51.
13. Lee PY, Chien Y, Chiou GY, Lin CH, Chiou CH, Tarng DC. Induced pluripotent stem cells without c-Myc attenuate acute kidney injury via down-regulating the signaling of oxi-dative stress and infammation in ischemia-reperfusion rats. Cell Transplant. 2012;21:2569-2585.
14. Lin TM, Chang HW, Wang KH, et al. Isolation and identifca-tion of mesenchymal stem cells from human lipoma tissue. Biochem Biophys Res Commun. 2007;361:883-889.
15. Gronthos S, Franklin DM, Leddy HA, Robey PG, Storms RW, Gimble JM. Surface protein characterization of human adipose tissue-derived stromal cells. J Cell Physiol. 2001;189:54-63.
16. Zuk PA, Zhu M, Ashjian P, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002;13:4279-4295.
17. Mitchell JB, McIntosh K, Zvonic S, et al. Immunophenotype of human adipose-derived cells: Temporal changes in stro-mal-associated and stem cell-associated markers. Stem Cells 2006;24:376-385.
18. Yasuda M, Miyachi Y, Ishikawa O, Takahashi K. Spatial expressions of fbronectin and integrins by human and rodent dermal fbroblasts. Br J Dermatol. 2006;155:522-531.
19. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identifcation of programmed cell death in situ via specifc labeling of nuclear DNA fragmentation. J Cell Biol. 1992;119:493-501.
20. Chien CT, Lee PH, Chen CF, Ma MC, Lai MK, Hsu SM. De novo demonstration and co-localization of free-radical production and apoptosis formation in rat kidney subjected to ischemia/reperfusion. J Am Soc Nephrol. 2001;12:973-982.
21. Tögel F, Weiss K, Yang Y, Hu Z, Zhang P, Westenfelder C. Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury. Am J Physiol Renal Physiol. 2007;292:F1626-F1635.
22. Imberti B, Morigi M, Tomasoni S, et al. Insulin-like growth factor-1 sustains stem cell mediated renal repair. J Am Soc Nephrol. 2007;18:2921-2928.
23. Deak E, Rüster B, Keller L, et al. Suspension medium infu-ences interaction of mesenchymal stromal cells with endo-thelium and pulmonary toxicity after transplantation in mice. Cytotherapy 2010;12:260-264.
24. Vulliet PR, Greeley M, Halloran SM, MacDonald KA, Kittleson MD. Intra-coronary arterial injection of mesen-chymal stromal cells and microinfarction in dogs. Lancet 2004;363:783-784.
25. Furlani D, Ugurlucan M, Ong L, et al. Is the intravas-cular administration of mesenchymal stem cells safe? Mesenchymal stem cells and intravital microscopy. Microvasc Res. 2009;77:370-376.
26. Toma C, Wagner WR, Bowry S, Schwartz A, Villanueva F. Fate of culture-expanded mesenchymal stem cells in the micro-vasculature: In vivo observations of cell kinetics. Circ Res. 2009;104:398-402.
27. Freyman T, Polin G, Osman H, et al. A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. Eur Heart J. 2006;27:1114-1122.
28. Fischer UM, Harting MT, Jimenez F, et al. Pulmonary passage is a major obstacle for intravenous stem cell delivery: The pulmonary frst-pass effect. Stem Cells Dev. 2009;18:683-692.
29. Gao J, Dennis JE, Muzic RF, Lundberg M, Caplan AI. The dynamic in vivo distribution of bone marrow-derived mes-enchymal stem cells after infusion. Cells Tissues Organs 2001;169:12-20.
30. Fang B, Song YP, Liao LM, Han Q, Zhao RC. Treatment of severe therapy-resistant acute graft-versus-host disease with human adipose tissue-derived mesenchymal stem cells. Bone Marrow Transplant. 2006;38:389-390.
31. Ringdén O, Uzunel M, Rasmusson I, et al. Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation 2006;81:1390-1397.
32. Le Blanc K, Frassoni F, Ball L, et al.; Developmental Committee of the European Group for Blood and Marrow Transplantation. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: A phase II study. Lancet 2008;371:1579-1586.